Howard J - Search Results

1

Leucocyte telomere length in patients with sickle cell disease.

Drašar ER, Jiang J, Gardner K, Howard J, Vulliamy T, Vasavda N, Thein SL. Drašar ER, et al. Among authors: howard j. Br J Haematol. 2014 Jun;165(5):725-7. doi: 10.1111/bjh.12776. Epub 2014 Feb 14. Br J Haematol. 2014. PMID: 24666270 Free article. No abstract available.

2

Cannabis use in sickle cell disease: a questionnaire study.

Howard J, Anie KA, Holdcroft A, Korn S, Davies SC. Howard J, et al. Br J Haematol. 2005 Oct;131(1):123-8. doi: 10.1111/j.1365-2141.2005.05723.x. Br J Haematol. 2005. PMID: 16173972 Free article.

3

The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.

Vasavda N, Badiger S, Rees D, Height S, Howard J, Thein SL. Vasavda N, et al. Among authors: howard j. Br J Haematol. 2008 Nov;143(4):589-92. doi: 10.1111/j.1365-2141.2008.07375.x. Epub 2008 Sep 1. Br J Haematol. 2008. PMID: 18764867 Free article.

4

The clinical care of adult patients with sickle cell disease.

Olujohungbe A, Howard J. Olujohungbe A, et al. Among authors: howard j. Br J Hosp Med (Lond). 2008 Nov;69(11):616-9. doi: 10.12968/hmed.2008.69.11.31646. Br J Hosp Med (Lond). 2008. PMID: 19069260

5

Pain management and quality of life in sickle cell disease.

Howard J, Thomas VJ, Rawle HM. Howard J, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):347-52. doi: 10.1586/erp.09.32. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19670995 Review.

6

Moving young people with sickle cell disease from paediatric to adult services.

Howard J, Woodhead T, Musumadi L, Martell A, Inusa BP. Howard J, et al. Br J Hosp Med (Lond). 2010 Jun;71(6):310-4. doi: 10.12968/hmed.2010.71.6.48435. Br J Hosp Med (Lond). 2010. PMID: 20551868 Review.

7

Community-acquired Salmonella bacteraemia in patients with sickle-cell disease 1969-2008: a single centre study.

Richards LH, Howard J, Klein JL. Richards LH, et al. Among authors: howard j. Scand J Infect Dis. 2011 Feb;43(2):89-94. doi: 10.3109/00365548.2010.526958. Epub 2010 Oct 21. Scand J Infect Dis. 2011. PMID: 20964487

8

Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.

Daniel Y, Hill K, Inusa B, Thein SL, Howard J. Daniel Y, et al. Among authors: howard j. Hemoglobin. 2011;35(4):406-10. doi: 10.3109/03630269.2011.592555. Hemoglobin. 2011. PMID: 21797706

9

Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.

Vasavda N, Woodley C, Allman M, Drašar E, Awogbade M, Howard J, Thein SL. Vasavda N, et al. Among authors: howard j. Br J Haematol. 2012 Apr;157(2):249-52. doi: 10.1111/j.1365-2141.2011.08937.x. Epub 2011 Nov 15. Br J Haematol. 2012. PMID: 22082280 Free article. Clinical Trial. No abstract available.

10

The obstetric management of sickle cell disease.

Howard J, Oteng-Ntim E. Howard J, et al. Best Pract Res Clin Obstet Gynaecol. 2012 Feb;26(1):25-36. doi: 10.1016/j.bpobgyn.2011.10.001. Epub 2011 Nov 22. Best Pract Res Clin Obstet Gynaecol. 2012. PMID: 22113135 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,804 results

Search Page

Filters